Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.81B
Enterprise Value6.92B
P/E Ratio147.37
PEG Ratio-2.01
Price/Sales Ratio5.95
Price/Book Ratio5.09
Enterprise/Revenue6.16
Enterprise/EBITDA89.32

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue1.22B
Revenue/Share9.64
Gross Profit634.32M
EBITDA277.26M
Net Income203.87M
Diluted EPS1.86

Balance Sheet

Total Cash544.94M
Total Cash/Share4.99
Total Debt682.7M
Total Debt/Equity0.57
Current Ratio1.71
Book Value Per Share11.12

Price History

52-Week Change-7.05
52-Week High80.7
52-Week Low46.68
Moving Average 50 Days68.47
Moving Average 200 Days62.65

Statistics

Average Volume2.92M
Shares Outstanding112M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.33
Payout Ratio0.74
Last Split Factor7:5
Last Split DateMay 12, 2023
AD